Mulligan SP, Opat S, Cheah CY, Kuss B, et al. Real-world experience of Australian and New Zealand patients with chronic lymphocytic leukemia and mantle cell lymphoma accessing ibrutinib through a Named Patient Program. Leuk Lymphoma 2022 Nov 24:1-7. doi: 10.1080/10428194.2022.2148220.
PMID: 36423351